Clinical Trial Update: Study of Low-Dose Intravenous Decitabine in Patients Aged > 60 Years With Acute Myeloid Leukemia [Phase 2]

View source ↗

Summary

This update reports on a Phase 2 trial evaluating low-dose intravenous decitabine in patients aged over 60 with acute myeloid leukemia. The study status is comp…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• Dacogen (decitabine)

Snippet

Sponsor: University Hospital Freiburg | Conditions: Acute Myeloid Leukemia | Phase 2 | Status: COMPLETED